GEOSPATIAL ANALYSIS OF PEDIATRIC TUBERCULOSIS IN BOHOL, PHILIPPINES: DISEASE CLUSTERS AND ACCESS TO CARE [PDF]
, 2019 Worldwide, children represent approximately 10% of global tuberculosis (TB) cases. We recently reported a high tuberculin skin test (TST)-positive prevalence (355/5,476; weighted prevalence=6.4%) among children (\u3c15 years) throughout the island of ...
LEINING, LAUREN M
core +1 more source
Over 90% of Childhood BCG Vaccine-Induced Keloids in Japan Occur in Women. [PDF]
Dermatol Ther (Heidelb), 2023 Noishiki C +3 more
europepmc +1 more source
Neonatal BCG Vaccine and Response to the Tuberculin Test in BCG Vaccinated Children in Contact with Tuberculosis Patients in Recife, Brazil [PDF]
, 2004 Maria de Fátima P. M. Albuquerque
openalex +1 more source
Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
, 2020 Kaufmann, S.
core +1 more source
Is the BCG Vaccine an Answer to Future Pandemic Preparedness? [PDF]
Vaccines (Basel), 2022 Khan NH +3 more
europepmc +1 more source
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults. [PDF]
Front Immunol, 2023 Pacheco GA +8 more
europepmc +1 more source
Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity [PDF]
, 2005 Marcus A. Horwitz +3 more
openalex +1 more source
Vaccinations for the prevention of tuberculosis
Биопрепараты: Профилактика, диагностика, лечение, 2018 BCG vaccine for tuberculosis was developed nearly 100 years ago and still remains the only medicine for specific immunological prevention of tuberculosis.
D. T. Levi, N. V. Aleksandrova
doaj
Report of 16 Years of the BCG Vaccine under the Expanded Program on Immunizations in Mexico (2006-2021). [PDF]
Vaccines (Basel), 2023 Romero-Feregrino R +5 more
europepmc +1 more source